Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Within-subject, Placebo-controlled, Single-blind Study to Evaluate the Efficacy of ELAPR002f in Females and Males With Atrophic Acne Scars

NCT03056235 is registered in ClinicalTrials.gov with Elastagen Pty Ltd as lead sponsor.

NCT NCT03056235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03056235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Within-subject, Placebo-controlled, Single-blind Study to Evaluate the Efficacy of ELAPR002f in Females and Males With Atrophic Acne Scars
Lead sponsor
Elastagen Pty Ltd
Phase
Not applicable
Overall status
Completed
Start date
March 27, 2017
Completion date
September 11, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic acne scar